Projects funded by the NCN
Novel human topoisomerase II inhibitors as anticancer agents
2018/29/N/NZ7/01726
Keywords:
molecular modeling thiosemicarbazide derivatives type II topoisomerase inhibitors anticancer activity
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
- NZ7_15: Toxicology
- NZ5_7: Human disease treatment
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Lublinie, Wydział Nauk o Zdrowiu
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 15 - announced on 2018-03-15
Amount awarded: 209 558 PLN
Project start date (Y-m-d): 2019-04-12
Project end date (Y-m-d): 2023-04-11
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.